Skip to main content

AlphaCentric Advisors LLC

SEC CIK
0001913464
Latest filing
Jul 24, 2026

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by AlphaCentric Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings

Shares (Q2 2026)
9,866
Value
$369.2K
% of portfolio
0.3%
Quarters held
3
Since Q2 2023
Holdings of CRNX by AlphaCentric Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,866$369.2K0.3%+9,866NewHolders
Q4 20230$00.0%−82,000−100.0%Sold outHolders
Q3 202382,000$2.44M1.4%+35,000+74.5%AddedHolders
Q2 202347,000$846.9K0.5%+47,000NewHolders